3Harvey RF,Bradshaw JM.A simple index of inflammatory bowel disease activity[J].Lancet,1980,31(5): 514-9.
4Souto JC,Martinez E,Roca M,et al.Prothrombolic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease[J].Dig Dis Sci,1995;40(9): 1883-9.
5Li H,Zhu H,Xu CJ,et al.Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis[J].Cell,1998;94(4): 491-501.
6Thrompson NP,Wakefield AJ,Pounder RE.Inherited disorders of coagulation appears to protect against inflammatory bowel disease[J].Gastroenterology,1995;108(4):101.
7Lip GY,Lowe GD.Fibrin D-dimer: a useful clinical marker of thrombogenesis[J]? Clin Sci,1995;89(3):205.
8Bredbacka S,Blomback M,Wiman B,et al.Laboratory methods for detecting disseminated intravascular coagulation(DIC): new aspects[J].Acta Anaesthesiol Scand,1993;37(2): 125-38.
9Larsen TB,Nielsen JN,Fredholm L,et al.Platelets and anticoagulant capacity in patients with inflammatory bowel disease[J].Pathophysiol Haemost Thromb,2002;32(2): 92-6.
二级参考文献12
1Thompson NP, Wakefidd AJ, Pounder RE. Inherited diseases of coagulation appear to protect against inflammatory bowel disease.Gastroenterology, 1995, 108(4) : 1011 -- 1015.
2Dhillon AP,Anthongy A, Sim R, et al. Mucosal capillary thrombi in rectal biopsies. Histopatbology, 1992;21 (2) :127~133.
3Gaffney PR, Doyle CT, Gaffney A, et al. Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterol,1995;90 (2): 220~223.
4Folwaczny C, Wiehecke B, Loeschke K. Unfractioned heparin in the therapy of patlents with highly active inflammatory bowel disease .Am J Gastroenterol, 1999;94(6): 1551--1555.
5Ang YS, Mahrnud N, White B ,et al. Randomizexl comparison of unfractioned heparinwith ccorficosteroids in seveze active inflammatory bowel disease. Aliment Pharmacol Ther,2000;14(8) : 1015--1022.
6Berendt W. Aichbichler,Wolfgang Petritsch,Gerhard A. Reicht,Heimo H. Wenzl,Andreas J. Eherer,Thomas A. Hinterleitner,Piet Auer-Grumbach,Guenter J. Krejs.Anti-Cardiolipin Antibodies in Patients with Inflammatory Bowel Disease[J].Digestive Diseases and Sciences.1999(4)
7I. E. Koutroubakis,E. Petinaki,E. Anagnostopoulou,H. Kritikos,I. A. Mouzas,E. A. Kouroumalis,O. N. Manousos.Anti-cardiolipin and Anti-β2-glycoprotein I Antibodies in Patients with Inflammatory Bowel Disease[J].Digestive Diseases and Sciences.1998(11)
8Antoni Stadnicki,Maciej Gonciarz,Tomasz J. Niewiarowski,Jacek Hartleb,Marek Rudnicki,Nancy B. Merrell,Raul A. Dela Cadena,Robert W. Colman.Coagulation Systems and Neutrophils in the Activation of Plasma Contact and Active Phase of Ulcerative Colitis[J].Digestive Diseases and Sciences.1997(11)
9Dr. Joan Carles Souto MD,Elisabet Martínez BSc,Martí Roca PhD,José Mateo MD,Joan Pujol MD,Dolors González MD,Jordi Fontcuberta PhD.Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease[J].Digestive Diseases and Sciences.1995(9)
10Dr. Maureen G. Conlan MD,William D. Haire MD,David A. Burnett MD.Prothrombotic abnormalities in inflammatory bowel disease[J].Digestive Diseases and Sciences.1989(7)
